sub:assertion {
d:DB00234 v:identifier "DB00234" ;
v:namespace "drugbank" ;
v:uri "http://bio2rdf.org/drugbank:DB00234" ;
v:x-identifiers.org <
http://identifiers.org/drugbank/DB00234> ;
dv:drugbank-id "APRD00198" , "DB00234" ;
dv:x-atc <
http://bio2rdf.org/atc:N06AX18> ;
dv:x-bindingdb <
http://bio2rdf.org/bindingdb:35226> ;
dv:x-cas <
http://bio2rdf.org/cas:98769-81-4> ;
dv:x-chemspider <
http://bio2rdf.org/chemspider:59268> ;
dv:x-pharmgkb <
http://bio2rdf.org/pharmgkb:PA144614921> ;
dv:x-pubchemcompound <
http://bio2rdf.org/pubchem.compound:65856> ;
dv:x-pubchemsubstance <
http://bio2rdf.org/pubchem.substance:46504845> ;
dv:x-wikipedia <
http://bio2rdf.org/wikipedia:Reboxetine> ;
dct:description "Reboxetine is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine."@en ;
dct:identifier "drugbank:DB00234" ;
dct:title "Reboxetine"@en ;
a dv:Drug ;
rdfs:label "Reboxetine [drugbank:DB00234]"@en ;
rdfs:seeAlso <
http://www.drugbank.ca/drugs/DB00234> .
}